Please use this identifier to cite or link to this item:
|Title:||Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001|
|Author(s):||Hol, J. A.|
Lopez-Yurda, M. I.
Van Tinteren, H.
Van Grotel, M.
De Camargo, B.
Ramírez-Villar, G. L.
Van den Heuvel-Eibrink, M. M.
|Year of Publication:||2019|
|DDC notations:||610 Medicine and health|
|Publikation type:||Journal Article|
|Abstract:||Background To enhance risk stratification for Wilms tumour (WT) in a pre-operative chemotherapy setting, we explored the prognostic significance and optimal age cutoffs in patients treated according to International Society of Paediatric Oncology Renal Tumour Study Group (SIOP-RTSG) protocols. Methods Patients(6 months-18 years) with unilateral WT were selected from prospective SIOP 93– 01 and 2001 studies(1993–2016). Martingale residual analysis was used to explore optimal age cutoffs. Outcome according to age was analyzed by uni- and multivariable analysis, adjusted for sex, biopsy(yes/no), stage, histology and tumour volume at surgery. Results 5631 patients were included; median age was 3.4 years(IQR: 2–5.1). Estimated 5-year event-free survival (EFS) and overall survival (OS) were 85%(95%CI 83.5–85.5) and 93% (95%CI 92.0–93.4). Martingale residual plots detected no optimal age cutoffs. Multivariable analysis showed lower EFS with increasing age(linear trend P<0.001). Using previously described age categories, EFS was lower for patients aged 2-4(HR 1.34, P = 0.02), 4-10 (HR 1.83, P<0.0001) and 10–18 years(HR 1.74, P = 0.01) as compared to patients aged 6 months-2 years. OS was lower for patients 4–10 years(HR 1.67, P = 0.01) and 10–18 years (HR 1.87, P = 0.04), but not for 2–4 years(HR 1.29, P = 0.23). Higher stage, histological risk group and tumour volume were independent adverse prognostic factors. Conclusion Although optimal age cutoffs could not be identified, we demonstrated the prognostic significance of age as well as previously described cutoffs for EFS (2 and 4 years) and OS (4 years) in children with WT treated with pre-operative chemotherapy. These findings encourage the consideration of age in the design of future SIOP-RTSG protocols.|
|DOI of the first publication:||10.1371/journal.pone.0221373|
|URL of the first publication:||https://doi.org/10.1371/journal.pone.0221373|
|Link to this record:||urn:nbn:de:bsz:291--ds-406474|
|Date of registration:||28-Sep-2023|
|Description of the related object:||Supporting information|
|Faculty:||M - Medizinische Fakultät|
|Department:||M - Pädiatrie|
|Professorship:||M - Prof. Dr. Norbert Graf|
|Collections:||SciDok - Der Wissenschaftsserver der Universität des Saarlandes|
This item is licensed under a Creative Commons License